Search Result "Nuclear erythroid 2"
Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 14 Year: 2019 Page: 1643-1652
Author(s): Asis Bala,Shravani Sripathi Panditharadyula
Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future
Journal: Current Molecular Medicine
Volume: 21 Issue: 10 Year: 2021 Page: 819-831
Author(s): Zexi Liao,Jiaxin Li,Jingjing Wu,Jing Liu,Shuming Sun
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 873-883
Author(s): Lucia Manzoli, Sara Mongiorgi, Cristina Clissa, Carlo Finelli, Anna Maria Billi, Alessandro Poli, Marilisa Quaranta, Lucio Cocco, Matilde Y. Follo
Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 8 Year: 2012 Page: 1015-1029
Author(s): Hemant Kumar,Sushruta Koppula,In-Su Kim,Sandeep Vasant More,Byung-Wook Kim,Dong-Kug Choi
Contribution of NRF2 in Gastrointestinal Protection from Oxidative Injury
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 18 Year: 2018 Page: 2023-2033
Author(s): Akinori Yanaka
Basic Leucine Zipper Protein Nuclear Factor Erythroid 2ârelated Factor 2as a Potential Therapeutic Target in Brain Related Disorders
Journal: Protein & Peptide Letters
Volume: 29 Issue: 8 Year: 2022 Page: 676-691
Author(s):
Role of Natural Nuclear Factor Erythroid-2-related Factor 2 (Nrf2)Activators in Oral and Head and Neck Cancer Treatment
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 6 Year: 2023 Page: 425-427
Author(s):
The Regulatory Role of NRF-2 in Rheumatoid Arthritis
Ebook: Free Radical Biology of Endocrine, Metabolic & Immune Disorders
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815049220122010007
Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2345-2348
Author(s): Sara Mongiorgi, Matilde Y. Follo, Yong Ryoul Yang, Stefano Ratti, Lucia Manzoli, James A. McCubrey, Anna Maria Billi, Pann-Ghill Suh, Lucio Cocco
Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury byRegulating Metastasis-associated Lung Adenocarcinoma Transcript1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis
Journal: Protein & Peptide Letters
Volume: 31 Issue: 2 Year: 2024 Page: 116-127
Author(s):